Leveraging abundant experience and achievements, various modifications such as phosphorothioate can be achieved!
Ajinomoto Bio-Pharma Services and GeneDesign have extensive experience and a proven track record in LNA oligonucleotide synthesis and oligonucleotide synthesis that includes BNA. "LNA" is a type of synthetic nucleic acid known for its stability and specificity to complementary strands, while "BNA" is a general term for synthetic nucleic acids that are known to have high stability and increased specificity to complementary strands. Our company is capable of various modifications, including phosphorothioate modification and terminal modifications, in addition to long-chain DNA-LNA chimeric oligos and DNA-BNA chimeric oligos. 【Features】 ■ LNA Synthesis - Supplied by our company for research and development purposes - Supports terminal modifications, large-scale synthesis, and shipping for in vivo experimental grades ■ BNA Synthesis - Established technology for synthesizing and purifying oligonucleotides with various combinations - Provides LNA, BNA-NC (N-Me), and BNA-NC (N-H) *For more details, please refer to the external link page or feel free to contact us.
Inquire About This Product
basic information
For more details, please refer to the external link page or feel free to contact us.
Price information
We have set a special discounted price for LNA Gapmers (approximately 20mer, fully phosphorothioated). We offer a consistent price regardless of the number of bases, so please feel free to consult with us.
Price range
P2
Delivery Time
P4
※*It may vary depending on the production volume. Please feel free to contact us.
Applications/Examples of results
For more details, please refer to the external link page or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Ajinomoto Bio-Pharma Services and Gene Design, Inc. are engaged in the production of oligonucleotides, incorporating the latest technologies and patent licenses from various research institutions. We supply distinctive nucleic acid materials, including the introduction of artificially modified nucleic acids and the addition of functional molecules, contributing to the development of new technologies in the gene-related fields (such as drug development, diagnostic technology development, and bio-research technology development). Currently, the demand for various synthetic nucleic acids is expanding from cell culture levels to animal testing and further to clinical trials. Our company has established a system capable of supplying everything from research reagents to investigational drugs at all scales, and we are advancing research and development daily as a company that can significantly contribute to the creation of nucleic acid pharmaceuticals and the practical application of diagnostic systems. For the future of medicine, we aim to be a company that contributes to the welfare and health of people through the development of nucleic acid manufacturing technologies, actively working on the development of next-generation nucleic acid drugs and diagnostic materials.
![[Case Study] Sensor Reduces Sorting Time by Half! Higashi Nihon Recycling Systems](https://image.www.ipros.com/public/product/image/add/2001211187/IPROS42997668617422795954.png?w=280&h=280)
![[Case Study] 90% Recycling Rate of Waste Plastics! Meiwa Packs](https://image.www.ipros.com/public/product/image/c34/2001211193/IPROS77251652406533655175.png?w=280&h=280)
